{
    "paper_id": "79fe7179b5223cf041ff568e3a4b8de00b9f5c4e",
    "metadata": {
        "title": "High speed large scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled with high content screening 2 Running title: An automated system for SARS-CoV-2 isolation 3 *Corresponding authors",
        "authors": [
            {
                "first": "Rania",
                "middle": [],
                "last": "Francis",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Institut Hospitalo-Universitaire M\u00e9diterran\u00e9e-Infection",
                    "location": {
                        "addrLine": "19-21 Boulevard Jean Moulin",
                        "postCode": "13005"
                    }
                },
                "email": ""
            },
            {
                "first": "Marion",
                "middle": [],
                "last": "Le Bideau",
                "suffix": "",
                "affiliation": {
                    "laboratory": "UMR Microbes",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Priscilla",
                "middle": [],
                "last": "Jardot",
                "suffix": "",
                "affiliation": {
                    "laboratory": "UMR Microbes",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Clio",
                "middle": [],
                "last": "Grimaldier",
                "suffix": "",
                "affiliation": {
                    "laboratory": "UMR Microbes",
                    "institution": "",
                    "location": {}
                },
                "email": ""
            },
            {
                "first": "Didier",
                "middle": [],
                "last": "Raoult",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Institut Hospitalo-Universitaire M\u00e9diterran\u00e9e-Infection",
                    "location": {
                        "addrLine": "19-21 Boulevard Jean Moulin",
                        "postCode": "13005"
                    }
                },
                "email": ""
            },
            {
                "first": "Jacques",
                "middle": [],
                "last": "Yaacoub",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Bou",
                "middle": [],
                "last": "Khalil",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Institut Hospitalo-Universitaire M\u00e9diterran\u00e9e-Infection",
                    "location": {
                        "addrLine": "19-21 Boulevard Jean Moulin",
                        "postCode": "13005"
                    }
                },
                "email": ""
            },
            {
                "first": "Bernard",
                "middle": [
                    "La"
                ],
                "last": "Scola",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Institut Hospitalo-Universitaire M\u00e9diterran\u00e9e-Infection",
                    "location": {
                        "addrLine": "19-21 Boulevard Jean Moulin",
                        "postCode": "13005"
                    }
                },
                "email": "bernard.la-scola@univ-amu.fr"
            }
        ]
    },
    "abstract": [
        {
            "text": "SARS-CoV-2, a novel coronavirus infecting humans, is responsible for the current COVID-19 20 global pandemic. If several strains could be isolated worldwide, especially for in-vitro drug 21 susceptibility testing and vaccine development, few laboratories routinely isolate SARS-CoV-2.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "This is due to the fact that the current co-culture strategy is highly time consuming and requires 23 working in a biosafety level 3 laboratory. In this work, we present a new strategy based on high 24 content screening automated microscopy (HCS) allowing large scale isolation of SARS-CoV-2 25 from clinical samples in 1 week. A randomized panel of 104 samples, including 72 tested 26 positive by RT-PCR and 32 tested negative, were processed with our HCS procedure and were 27 compared to the classical isolation procedure. Isolation rate was 43 % with both strategies on 28 RT-PCR positive samples, and was correlated with the initial RNA viral load in the samples, 29 where we obtained a positivity threshold of 27 Ct. Co-culture delays were shorter with HCS 30 strategy, where 80 % of the positive samples were recovered by the third day of co-culture, as 31 compared to only 25 % with the classic strategy. Moreover, only the HCS strategy allowed us to 32 recover all the positive elements after 1 week of co-culture. This system allows rapid and 33 automated screening of clinical samples with minimal operator work load, thus reducing the risks 34 of contamination.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "35",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Plates were incubated for 24 hours at 37\u00b0C in a 5 % CO2 atmosphere to allow cell adhesion.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Infection was then carried out with 50 \u00b5l of the viral stock suspension diluted up to 10 -10 . The 81 plates were centrifuged for 1 hour at 700 x g and the total volume per well was adjusted to 250 82 \u00b5l with culture medium. Uninfected cells were considered negative control. ROI_TotalIntenCh3 respectively). These parameters were used to generate 2 clusters using K-108 means clustering algorithm and then the percentage of injured cells per well was calculated, as 109 previously described(21). We then compared the percentage of injured cells obtained to the total 110 cell count in each well in order to detect cell lysis (ratio = % injured cells / cell count). confirm that this effect was due to SARS-CoV-2 and to negative wells to confirm that the lack of 135 cytopathic effect was not due to microscopically undetectable minimal viral growth. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "80"
        },
        {
            "text": "The data extracted from the images were analyzed in the dedicated application in R Studio. The ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "157"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "WHO Director-General's opening remarks at the Mission briefing on",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Severe acute respiratory syndrome 248 coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic 249 and the challenges",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Shih",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Ko",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "R"
                    ],
                    "last": "Hsueh",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Antimicrob Agents",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "A novel coronavirus from 252 patients with pneumonia in China",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "727--733",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Diagnosis, Therapeutics, and Vaccines for Novel",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "COVID-19)",
            "authors": [],
            "year": 2019,
            "venue": "J Microbiol Biotechnol",
            "volume": "30",
            "issn": "",
            "pages": "313--324",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "COVID-19 treatment by repurposing drugs until the vaccine is 257 in sight",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Phadke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Saunik",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Drug Dev Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Hydroxychloroquine and azithromycin as a 261 treatment of COVID-19: results of an open-label non-randomized clinical trial",
            "authors": [
                {
                    "first": "J-M",
                    "middle": [],
                    "last": "Rolain",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Brouqui",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Raoult",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J",
            "volume": "262",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Antimicrob Agents 105949",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Breakthrough: Chloroquine phosphate has shown apparent 264 efficacy in treatment of COVID-19 associated pneumonia in clinical studies",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Biosci 265 Trends",
            "volume": "14",
            "issn": "",
            "pages": "72--73",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting 268 SARS-CoV-2 infection in vitro",
            "authors": [],
            "year": null,
            "venue": "Cell Discov",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus 271 (2019-nCoV) in vitro",
            "authors": [],
            "year": null,
            "venue": "Cell Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Park 273 SJ. 2020. Case of the index patient who caused tertiary transmission of coronavirus 274 disease 2019 in Korea: The application of lopinavir/ritonavir for the treatment of COVID-275 19 pneumonia monitored by quantitative RT-PCR",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lim",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jeon",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "Y"
                    ],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Seong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Choe",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "J Korean Med Sci",
            "volume": "35",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "The SARS-CoV-2 Vaccine Pipeline: 277 an Overview",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "H"
                    ],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Strych",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "J"
                    ],
                    "last": "Hotez",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Bottazzi",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Curr Trop Med Reports",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Preliminary identification of potential 279 vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Quadeer",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Mckay",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Deployment of 285 convalescent plasma for the prevention and treatment of COVID-19",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Pollack",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "T"
                    ],
                    "last": "Nicholson",
                    "suffix": ""
                },
                {
                    "first": "L-A",
                    "middle": [],
                    "last": "Pirofski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Bailey",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Tobian",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Invest",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Immune responses in COVID-19 and potential 287 vaccines: Lessons learned from SARS and MERS epidemic",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Prompetchara",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ketloy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Palaga",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Asian Pacific J allergy",
            "volume": "288",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The Laboratory Diagnosis of 290 COVID-19 Infection: Current Issues and Challenges",
            "authors": [
                {
                    "first": "Y-W",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Schmitz",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Persing",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Stratton",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Microbiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Molecular Diagnosis of a Novel 293",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "Llm",
                    "middle": [],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "-nCoV) Causing an Outbreak of Pneumonia",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Coronavirus",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Clin Chem",
            "volume": "66",
            "issn": "",
            "pages": "549--555",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Improved molecular diagnosis of COVID-19 by the novel, highly 297 sensitive and specific COVID-19-RdRp/Hel real-time reverse transcription-polymerase 298 chain reaction assay validated in vitro and with clinical specimens",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yuen",
                    "suffix": ""
                },
                {
                    "first": "K-Y",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Microbiol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "A review of the 2019 Novel Coronavirus 300 (COVID-19) based on current evidence",
            "authors": [
                {
                    "first": "L-S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y-R",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D-W",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "Q-Q",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Antimicrob Agents",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Viral RNA load as determined by cell culture as a management tool for 303 discharge of SARS-CoV-2 patients from infectious disease wards",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Raoult",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Eur J Clin Microbiol",
            "volume": "304",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "High-throughput isolation of 306 giant viruses using high-content screening",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Francis",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ominami",
                    "suffix": ""
                },
                {
                    "first": "Bou",
                    "middle": [],
                    "last": "Khalil",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "La",
                    "middle": [],
                    "last": "Scola",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Commun Biol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "High-Content Screening, a Reliable System for Coxiella burnetii 309 Isolation from Clinical Samples",
            "authors": [
                {
                    "first": "La",
                    "middle": [],
                    "last": "Scola",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Microbiol",
            "volume": "58",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Ultrarapid diagnosis, 311 microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                },
                {
                    "first": "J-C",
                    "middle": [],
                    "last": "Lagier",
                    "suffix": ""
                },
                {
                    "first": "J-P",
                    "middle": [],
                    "last": "Baudoin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Khalil",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Scola",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "La",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Raoult",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Rapid viral 315 diagnosis and ambulatory management of suspected COVID-19 cases presenting at the 316 infectious diseases referral hospital",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Boschi",
                    "suffix": ""
                },
                {
                    "first": "La",
                    "middle": [],
                    "last": "Scola",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Raoult",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Million",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gautret",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Travel Med Infect Dis",
            "volume": "317",
            "issn": "2020",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Wuhan, China, then spread worldwide and was declared a pandemic by WHO on the 39 12 th of March 2020(1) , (2) , (3). This global health crisis has drawn the attention of the entire 40 scientific community who are working altogether to understand the reason of this outbreak and to 41 find a solution at the levels of rapid diagnosis and effective treatment(4). Several known drugs 42 have been repurposed to treat COVID-19 patients and have shown in-vitro and in-vivo 43 efficiency(5) , (6) , (7) , (8) , (9) , (10). Moreover, vaccine development is ongoing in several countries 44 around the world(11) , (12), in addition to potential plasma therapy(13) , (14). Laboratory diagnosis 45 is mainly based on molecular biology using specific RT-PCR systems to detect the virus in 46 clinical samples(15) , (16) , (17). However, during such pandemics, strain isolation is important, as 47 having the particle represents the key to all in-vitro research such as drug susceptibility testing 48 and vaccine development. Furthermore, culture allows access to all viral genomes since whole 49 genome sequencing techniques performed directly on samples have their limitations in terms of 50 sensitivity. 51 If routine culture was progressively abandoned in most virology laboratories, we believe 52 that isolating as many strains as possible allows to compare genomic sequences with phenotype 53 of infection, in vitro and in vivo. This would help understanding the epidemiological aspects of 54 this illness, its physiopathology and better target treatment and prevention(18",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "was performed with NucBlue\u2122 Live ReadyProbes\u2122 reagent (Molecular Probes,85    Life Technologies, USA). A concentration of 4 ng/ml was used (equivalent to 10 \u00b5l per well 86 directly from stock solution) and a different well was stained each day to avoid photo-bleaching 87 and possible cytotoxicity, as previously described(21).88Image acquisition and analysis were performed using the automated CellInsight\u2122 CX7 High89 Content Analysis Platform coupled with an automation system including an Orbitor\u2122 RS 90 Microplate mover and an incubator Cytomat\u2122 2C-LIN (Thermo Scientific). The HCS Studio 3.1 91 software was used to set up acquisition parameters using a 20x objective (0.45 NA), and to 92 define image analysis. Autofocus was performed on the fluorescence channel of the fluorescent 93 6 probe NucBlue (386 nm). This channel served as a primary mask for cell detection and 94 identification. The regions of interest (ROI) were then identified on brightfield images as a 95 Voronoi diagram derived from nuclear masks. Cell debris were removed using area cutoffs. The 96 entire well (80 fields per well) was screened on a daily basis and data were extracted and 97 analyzed in a dedicated application that we recently developed in R Studio\u00ae for the detection of 98 the intracellular bacteria, Coxiella burnetii(21). We optimized this application for the detection 99 of cytopathic effects caused by Covid-19.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Briefly, a database consisting of negative (uninfected cells) and positive (infected cells) controls 101 was generated. The data were used to define specific features allowing the discrimination 102 between the two groups. The following features were selected: the average, total and variation of 103 the nuclear fluorescence intensity per cell, the nuclear area, the skewness of the brightfield 104 intensity distribution, the kurtosis of the brightfield intensity distribution and the total intensity of 105 the brightfield within the regions of interest (",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Large scale co-culture of clinical samples112    We applied this strategy for the detection of SARS-CoV-2 in randomly chosen 104 anonymized 113 nasopharyngeal swab samples. Initial RT-PCR ranged from 12 Ct to 34 Ct in 72 samples, and 32 114 samples with negative initial PCR were used as negative controls. Sample preparation and co-115 culture were performed as previously described(6). Briefly, 500 \u00b5l of the sample were processed consisting of cells infected with a 10 -4 dilution of the IHUMI-3 strain were 120 considered. A centrifugation step (700 x g for 1 h) was performed to enhance the entrance of the 121 virus inside the cells. Plates were then incubated at 37\u00b0C and monitored for 7 days to search for 122 cytopathic effects. In parallel, the same samples were processed using the classical isolation 123 strategy based on the manual observation of cytopathic effects under an inverted microscope, in 124 order to validate our strategy(6) , (19) ,(22). For this strategy, co-cultures showing no cythopatic 125 effects after 1 week were sub-cultured at day 7 and day 14 onto a fresh monolayer of cells for a 126 complete observation of 3 weeks.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Results validation by scanning electron microscopy and RT-PCR128 Positive co-cultures were processed with both scanning electron microscopy (SEM) and RT-PCR 129 directly from culture supernatant to validate the presence of COVID-19 viral particles. Briefly, 130 the SEM was performed using the SU5000 microscope (Hitachi High-Tech Corporation, Tokyo, 131 Japan) allowing a rapid observation in about10 minutes without time consuming sample 132 preparations(22). RT-PCR protocol was performed as previously described by Amrane et al. 133 targeting the E gene(23). This RT-PCR was applied to wells showing a cytopathic effect to 134",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "Studio\u00ae and XLSTAT software were used to perform all statistical tests included in this l'Informatique et des Libert\u00e9s), collected data were anonymized. The study was 142 approved by the local ethics committee of IHU (Institut Hospitalo-Universitaire) represents the fluorescence and brightfield images acquired with the cx7 microscope at 148 days 1 and 6 post infection showing the early stages of infection of SARS-CoV-2 (Figure 1 -a, 149b) compared to advanced stages of infection and cell lysis(Figure 1 -g, h, i, j, k). Typical150 cytopathic effects consist of an increasing nuclear fluorescence intensity of the NucBlue 151 fluorescent probe, in addition to nuclear fragmentation. These observations resulted in an 152 increase in the average, total and variation intensity of the nucleus and a decrease in the nuclear 153 area on the fluorescence images. Adding to this, infected cells become round and form 154 aggregates resulting in an increasing total intensity, skewness and kurtosis on the brightfield 155 images. Finally, advanced stages of infection are represented by cell lysis.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "database of negative and positive controls served as training data for the clustering algorithm and 159 a baseline of 2 to 3 % injured cells was predicted in the negative training data compared to a 160 value of 50 to 55 % injured cells in the positive training data. The percentage of injured cells in 161 each condition was predicted and then divided by the total cell count per well. This ratio allowed 162 us to distinguish positive wells, showing cytopathic effects or cell lysis, from the negative 163 control wells consisting of uninfected cells (Figure 2-a). Cytopathic effects were detectable up 164until the dilution 10 -4 after 6 days of culture for the strain IHUMI-3 used in this study, which 165 corresponds to the viral titer obtained by TCID50.166    Furthermore, the automation system allowed us to monitor co-culture on a daily basis without 167 any intervention from the operators. The Momentum software was used to monitor the 168 automation system linked to the HCS microscope. A screening process was predefined, thus169    allowing the proper incubation of the plates followed by the automated handling of the screening 170 process at each specified time point.171 3. Screening of clinical samples with the new HCS and the classic isolation strategies 172 Among the panel of 104 samples processed on the CX7 microscope, 32 samples had a negative 173 initial PCR and were considered controls for system's sensitivity, and therefore the 174 corresponding co-cultures were negative. Among the remaining 72 samples, we managed to 175 isolate the virus from 31 samples using our automated detection system. The detection delay 176 ranged from 24 hours to 3 days for most samples and was prolonged to 6 days for samples with 177 low viral load. Figure 2-b shows examples of co-culture results obtained with the automated 178 detection system compared to the negative (uninfected cells) and positive (cells infected with the 179 viral strain IHUMI-3) controls. 180 Regarding the classic isolation strategy, 30 viral strains were isolated from the tested panel of 181 samples and the 32 samples with negative initial PCR had negative culture results as well. The 182 majority of strains were recovered after fourth days of co-culture and only few were isolated at 183 earlier stages. Three strains out of 30 were recovered after subcultures, 2 in the second week and 184 1 in the third week of co-culture. 185 A significantly higher percentage of positive samples was observed on a daily basis with the 186 HCS strategy (Figure 3). Moreover, the majority of positive samples were isolated by the third 187 day of co-culture using the HCS strategy, where 80 % positivity was obtained compared to only 188 26 % with the classic strategy (p value < 0.001). 189 To validate our results, positive co-cultures were processed to scanning electron microscopy to 190 confirm the presence of viral particles. We detected viral particles in the supernatant of all 191 11 samples that were detected as positive by the HCS strategy. Figure 4 shows an example of 192 particle detection in culture supernatant by SEM. RT-PCR performed on all wells correlated with 193 the results of the microscopy-based detection. We then correlated the isolation rates obtained 194 with both strategies to the initial viral RNA load (Figure 5). We obtained comparable isolation 195 rates with the HCS isolation strategy, as compared with the classic strategy. 196 Then, we correlated the isolation rates obtained with both strategies to the initial viral load (RT-197 PCR results) in each sample and the results are shown in figure 5. We obtained similar isolation 198 rates with the HCS isolation strategy as well as with the classic strategy. Moreover, we noticed 199 that most of the strains were recovered from samples with an initial viral load lower than 30 Ct 200 with both strategies. Therefore, we calculated the positivity threshold of the isolation rate 201 compared to the initial viral load in the samples using a ROC curve and we obtained a similar 202 positivity threshold of 27 Ct for both isolation strategies. a crucial factor, especially during pandemics, since all in-vitro analysis require having 207 the virus(4). Furthermore, the greater the number of strains isolated, the better the understanding 208 of the genetic diversity of this virus, especially since genome sequencing directly from samples 209 is limited to viral load and a very poor genome assembly is obtained when the viral load is 210 greater than 19 Ct (unpublished data). Developing an automated viral isolation technique was 211 thus necessary to overcome the subjective and time consuming manual microscopic 212 observations. In this work, we were able to co-culture a large amount of clinical samples and 213 monitor them with a fully automated system, which reduced the workload and time required 214 from laboratory technicians. The main advantage of this technique is the automation as it allows 215 limiting the risk of exposure or contamination of the personnel, since plate monitoring and data 216 analysis could be carried out from distance, thus avoiding direct contact and manual observations 217 of co-cultures. Similar isolation rates were obtained with both isolation strategies, which 218 validated the efficiency of our new automated system. Moreover, this isolation rate was obtained 219 in 1 week with the HCS strategy without any subcultures, contrary to the classic technique with 220 weekly subcultures for a complete incubation time of 3 weeks. Subsequently, since the loss of 221 cultivability of the virus in samples allows to consider patients at low risk of contamination, it 222 helps in the decision to discharge them from infectious diseases wards(19",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Kinetic monitoring of SARS-CoV-2 infection on Vero E6 cells over 6 days on the 322 CX7 microscope showing cytopathic effects at different stages of infection. Images show 323 respective fluorescence and brightfield images at different viral concentrations at days 1 and (l) negative control. Scale bars indicate 50 \u00b5m. Automated detection of SARS-CoV-2 in co-culture. (A) Ratio of the percentage of 328 injured cells on the total cell count of SARS-CoV-2 infected cells at different concentrations 329 compared to the negative control over a period of 6 days. (B) Ratio of the percentage of injured 330 cells on the total cell count of 10 clinical samples with different initial viral load over a period of 331 6 days. Initial viral load was negative in S1 and S2, 32 Ct in S3, 30 Ct in S4, 29 Ct in S5, 28 Ct 332 in S6, 23 Ct in S7, 22 Ct in S8, 16 Ct in S9 and 15 Ct in S10. Cumulative percentage of isolated strains per day using the classic and the new HCS 334 isolation strategies for samples detected as positive in co-culture. The dashed curve indicates the 335 polynomial regression curve. SEM images obtained with the SU5000 microscope showing SARS-CoV-2 particles 337 isolated from clinical samples (white arrows). Acquisition settings and scale bars are generated 338 on the original micrographs. Isolation rate of SARS-CoV-2 from nasopharyngeal samples according to initial Ct 340 values in samples (plain line) using the classic and the new HCS isolation strategies (40 Ct 341 represents the samples with a negative initial PCR). The dashed curve indicates the polynomial 342 regression curve.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "). A first application of this strategy was used by our group to evaluate the risk of contagiousness of patients for discharge from infectious diseases ward(19). However, the current co-culture strategy is tedious and time consuming, especially due to the large number of samples to be cultured. During the current COVID-19 outbreak, the samples without any observable cytopathogenic effects after 1 week of co-culture, were sub-cultured in blind and monitored for 3 weeks. The best would be to have an automated system allowing the rapid screening and monitoring of co-cultures at large scale. In previous works, we developed a screening strategy based on high content screening microscopy (HCS) for the isolation of environmental giant viruses in amoeba and the strict intracellular bacterium Coxiella burnetii(20) , (21). In this work, we used the same automated high-throughput method and adapted it for SARS-CoV-2 isolation from clinical samples with the objective to discard the negative co-cultures after 1 week and omit blind sub-cultures. Specific algorithms were applied to detect cytopathic effects in co-cultures at high throughput, which eliminates the subjectivity related to manual observations by the laboratory personnel. This strategy exhibited a similar isolation rate, but a lower co-culture delay 69 when compared to the classic technique routinely used for isolation, as we were able to detect all positive co-cultures in one week.",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "suspected samples in a safe and rapid way. Further work is underway to use this technique for large-scale drug susceptibility testing of SARS-CoV-2 strains isolated from patients. And, finally, the algorithms used here could be adapted and applied for the detection and isolation of other viruses from clinical samples in case of known and emerging viral diseases.This work was supported by a grant from the French State managed by the National Research Agency under the \"Investissements d'avenir (Investments for the Future)\" programme under the reference ANR-10-IAHU-03 (M\u00e9diterran\u00e9e Infection) and by the R\u00e9gion Provence-Alpes-C\u00f4te-234 d'Azur and the European funding FEDER PRIMI. We sincerely thank Takashi Irie, Kyoko Imai, Shigeki Matsubara, Taku Sakazume, Toshihide Agemura, Yusuke Ominami, Hisada Akiko and the Hitachi team in Japan Hitachi High-Tech Corporation, Toranomon Hills Business Tower, 1-17-1 Toranomon, Minato-ku, Tokyo 105-6409, Japan) for the collaborative study conducted together with IHU M\u00e9diterran\u00e9e Infection, and for the installation of a SU5000 microscope at the IHU M\u00e9diterran\u00e9e Infection facility.Conflict of interestAuthors would like to declare that Didier Raoult is a consultant for Hitachi High-Tech",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}